Zinc as a marker of affective disorders

Pharmacological Reports - Tập 65 - Trang 1512-1518 - 2013
Marcin Siwek1,2, Bernadeta Szewczyk2, Dominika Dudek1,2, Krzysztof Styczeń2,3, Magdalena Sowa-Kućma2, Katarzyna Młyniec2,4, Agata Siwek2,5, Leszek Witkowski2,3, Bartłomiej Pochwat2,5, Gabriel Nowak2,5
1Department of Psychiatry, Faculty of Medicine, Jagielonian University Medical Colege, Kopernika 21a, PL 31-501 Kraków, Poland
2Department of Neurobiology, Institute of Pharmacology, Polish Academy of Sciences and Center of Excelence in Neuropsychopharmacology, Smetna 12, PL 31-343 Kraków, Poland
3Department of Adult Psychiatry, University Hospital, Kopernika 21a, PL 31-501 Kraków, Poland
4Department of Toxicology, Faculty of Pharmacy, Jagielonian University Medical Colege, Medyczna 9, PL 30-688 Kraków, Poland
5Department of Pharmacobiology, Faculty of Pharmacy, Jagielonian University Medical Colege, Medyczna 9, PL 30-688 Kraków, Poland

Tài liệu tham khảo

Amani, 2010, Correlation between dietary zinc intakes and its serum levels with depression scales in young female students, Biol Trace Elem Res, 137, 150, 10.1007/s12011-009-8572-x Anderson, 2013, Increased IL-6 trans-signaling in depression: focus on the tryptophan catabolite pathway, melatonin and neuroprogression, Pharmacol Rep, 65, 1647, 10.1016/S1734-1140(13)71526-3 Bhalla, 2007, Neuroprotective effects of zinc on antioxidant defense system in lithium treated rat brain, Indian J Exp Biol, 45, 954 Chen, 1997, Differential sensitivity of recombinant N-methyl-D-aspartate receptor subtypes to zinc inhibition, Mol Pharmacol, 51, 1015, 10.1124/mol.51.6.1015 DiGirolamo, 2010, Randomized trial of the effect of zinc supplementation on the mental health of school-age children in Guatemala, Am J Clin Nutr, 92, 1241, 10.3945/ajcn.2010.29686 González-Estecha, 2011, Trace elements in bipolar disorder, J Trace Elem Med Biol, 25, S78, 10.1016/j.jtemb.2010.10.015 Gosek, 2012, Antidepressant effect of ketamine, a N-methyl-Daspartate (NMDA) glutamate receptor antagonist, in the therapy of treatment-resistant depression (Polish), Psychiatr Pol, 46, 283 Gould, 2005, Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs, Neuropsychopharmacology, 30, 1223, 10.1038/sj.npp.1300731 Grieger, 2009, Nutritional and functional status indicators in residents of a long-term care facility, J Nutr Elder, 28, 47, 10.1080/01639360802633979 Hansen, 1983, Copper and zinc deficiencies in association with depression and neurological findings, Biol Psychiatry, 18, 395 Ilouz, 2002, Inhibition of glycogen synthase kinase-3â by bivalent zinc ions: insight into the insulin-mimetic action of zinc, Biochem Biophys Res Commun, 295, 102, 10.1016/S0006-291X(02)00636-8 Irmisch, 2010, Zinc and fatty acids in depression, Neurochem Res, 35, 1376, 10.1007/s11064-010-0194-3 Janota, 2011, The level of cortisol, DHEA DHEA-s in plasma serum and the connection with the lipids and response to treatment in women with depression (Polish), Psychiatr Pol, 45, 861 Lamont, 2001, Repeated electroconvulsive stimulation but not antidepressant drugs, induces mossy fiber sprouting in the rat hippocampus, Brain Res, 893, 53, 10.1016/S0006-8993(00)03287-X Little, 1989, Altered zinc metabolism in mood disorder patients, Biol Psychiatry, 26, 646, 10.1016/0006-3223(89)90093-0 Maes, 1994, Hipozincemia in depression, J Affect Disord, 31, 135, 10.1016/0165-0327(94)90117-1 Maes, 1999, Lower serum zinc in major depression in relation to changes in serum acute phase proteins, J Affect Disord, 56, 189, 10.1016/S0165-0327(99)00011-7 Maes, 1991, Anthropometric and biochemical assessment of the nutritional state in depression: evidence for lower visceral protein plasma levels in depression, J Affect Disord, 23, 25, 10.1016/0165-0327(91)90032-N Maes, 1997, Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness, Biol Psychiatry, 42, 269, 10.1016/S0006-3223(96)00365-4 Manser, 1989, Trace elements studies on Karachi population Part IV: Blood copper, zinc, magnesium and lead levels in psychiatric patients with depression, mental retardation and seizure disorders, J Pak Med Assoc, 39, 269 McLoughlin, 1990, Zinc in depressive disorder, Acta Psychiatr Scand, 82, 451, 10.1111/j.1600-0447.1990.tb03077.x Młyniec, 2013, Zinc deficiency alters responsiveness to antidepressants in mice, Pharmacol Rep, 65, 579, 10.1016/S1734-1140(13)71035-1 Młyniec, 2013, The role of the GPR39 receptor in zinc deficient-animal model of depression, Behav Brain Res, 238, 30, 10.1016/j.bbr.2012.10.020 Młyniec, 2012, The time course of zinc deprivation-induced alterations of mice behavior in the forced swim test, Pharmacol Rep, 64, 567, 10.1016/S1734-1140(12)70852-6 Młyniec, 2013, GPR39 up-regulation after selective antidepressants, Neurochem Int, 62, 936, 10.1016/j.neuint.2013.02.024 Narang, 1991, Levels of cooper and zinc in depression, Indian J Physiol Pharmacol, 35, 272 Nguyen, 2009, Micronutrient supplementation may reduce symptoms of depression in Guatemalan women, Arch Latinoam Nutr, 59, 278 Noseworthy, 2000, Zinc deficiency exacerbates loss in blood-brain barrier integrity induced by hyperoxia measured by dynamic MRI, Proc Soc Exp Biol Med, 223, 175, 10.1046/j.1525-1373.2000.22324.x Nowak, 1999, Alterations in serum and brain trace element levels after antidepressant treatment Part I. Zinc, Biol Trace Elem Res, 67, 85, 10.1007/BF02784278 Nowak, 2003, Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study, Pol J Pharmacol, 55, 1143 Nowak, 1999, Serum trace elements in animal models and human depression Part I. Zinc, Human Psychopharmacol Clin Exp, 14, 83, 10.1002/(SICI)1099-1077(199903)14:2<83::AID-HUP74>3.0.CO;2-6 Paoletti, 2009, Zinc at glutamatergic synapses, Neuroscience, 158, 126, 10.1016/j.neuroscience.2008.01.061 Popovics, 2011, GPR39: a Zn2+-activated G protein-coupled receptor that regulates pancreatic, gastrointestinal and neuronal functions, Cell Mol Life Sci, 68, 85, 10.1007/s00018-010-0517-1 Ranjbar, 2013, Effects of zinc supplementation on efficacy of antidepressant therapy, inflammatory cytokines and brainderived neurotrophic factor in patients with major depression, Nutr Neurosci Salimi, 2008, Lower total serum protein, albumin and zinc in depression in an Iranian population, J Med Sci, 8, 5878, 10.3923/jms.2008.587.590 Salustri, 2010, Oxidative stress and brain glutamate-mediated excitability in depressed patients, J Affect Disord, 127, 321, 10.1016/j.jad.2010.05.012 Sensi, 2011, The neurophysiology and pathology of brain zinc, J Neurosci, 31, 16076, 10.1523/JNEUROSCI.3454-11.2011 Serafini, 2012, Neuroplasticity and major depression, the role of modern antidepressant drugs, World J Psychiatr, 2, 49, 10.5498/wjp.v2.i3.49 Siwek, 2009, Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study, J Affect Disord, 118, 187, 10.1016/j.jad.2009.02.014 Siwek, 2010, Serum zinc level in depressed patients during zinc supplementation of imipramine treatment, J Affect Disord, 126, 447, 10.1016/j.jad.2010.04.024 Siwek, 2006, Serum zinc as a peripheral marker of depression (Polish), Farmakoter Psychiatr Neurol, 3 Siwek, 2013, Oxidative stress markers in affective disorders, Pharmacol Rep, 65, 1558, 10.1016/S1734-1140(13)71517-2 Siwek, 2005, The role of zinc in the pathogenesis and treatment of affective disorders (Polish), Psychiatr Pol, 34, 899 Sowa-Kućma, 2011, Chronic treatment with zinc and antidepressants induces enhancement of presynaptic/extracellular zinc concentration in the rat prefrontal cortex, Amino Acids, 40, 249, 10.1007/s00726-010-0641-0 Stanley, 2002, Toxic trace metals in the mentally ill patients, Niger Postgrad Med J, 9, 199, 10.4103/1117-1936.171339 Swardfager, 2013, Zinc in depression: a metaanalysis, Biol Psychiatry, 74, 872, 10.1016/j.biopsych.2013.05.008 Swardfager, 2013, Potential roles of zinc in the pathophysiology and treatment of major depressive disorder, Neurosci Biobehav Rev, 37, 911, 10.1016/j.neubiorev.2013.03.018 Szewczyk, 2013, Zinc homeostasis and neurodegenerative disorders, Front Aging Neurosci, 19, 5 Szewczyk, 2002, Interaction of zinc with antidepressants in the forced swimming test in mice, Pol J Pharmacol, 54, 681 Szewczyk, 2011, The role of zinc in neurodegenerative inflammatory pathways in depression, Prog Neuropsychopharmacol Biol Psychiatry, 35, 693, 10.1016/j.pnpbp.2010.02.010 Szewczyk, 2012, Investigational NMDA receptor modulators for depression, Expert Opin Investig Drugs, 21, 91, 10.1517/13543784.2012.638916 Szewczyk, 2008, Antidepressant activity of zinc and magnesium in view of the current hypotheses of antidepressant action, Pharmacol Rep, 60, 588 Takeda, 2000, Movement of zinc and its functional significance in the brain, Brain Res Brain Res Rev, 34, 137, 10.1016/S0165-0173(00)00044-8 Vaidya, 1999, Hippocampal mossy fiber sprouting induced by chronic electroconvulsive seizures, Neuroscience, 89, 157, 10.1016/S0306-4522(98)00289-9 Van Hunsel, 1996, Lower total serum protein, albumin, and beta- and gamma-globulin in major and treatment-resistant depression: effect of antidepressant treatments, Psychiatry Res, 65, 159, 10.1016/S0165-1781(96)03010-7 Wójcik, 2006, Antepartum/postpartum depressive symptoms and serum zinc and magnesium levels, Pharmacol Rep, 58, 571 Zirpel, 2001, Zinc inhibition of group I mGluR mediated calcium homeostasis in auditory neurons, J Assoc Res Otolaryngol, 2, 180, 10.1007/s101620010082